Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ubaldi, F.
Right arrow Articles by Greco, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ubaldi, F.
Right arrow Articles by Greco, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 17, No. 6, 1544-1547, June 2002
© 2002 European Society of Human Reproduction and Embryology

Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates

F. Ubaldi1,3, L. Rienzi1, S. Ferrero1, R. Anniballo1, M. Iacobelli1, L. Cobellis2 and E. Greco1

1 Centre for Reproductive Medicine, European Hospital, Rome, 2 Department of Obstetrics and Gynaecology II, University of Naples, Naples, Italy

BACKGROUND: Glucocorticoids have been used in conjunction with zona dissection to improve pregnancy and implantation rates in IVF patients. The aim of this prospective randomized study was to evaluate the effect of low-dose prednisolone in addition to the standard protocol, on pregnancy and implantation rates in routine ICSI patients before and after embryo replacement. METHODS: A total of 313 patients in 360 consecutive cycles (patients <39 years old and with three or less than three ICSI attempts) performed at our centre were randomly assigned by computer-generated list to receive either prednisolone (10 mg/day in two divided doses), starting on the first day of ovarian stimulation and continuing for 4 weeks (group A), or no treatment (group B). RESULTS: The mean age, number of previously failed IVF attempts, basal FSH levels and the mean rank of trials were comparable between groups A and B. The mean (± SD) number of metaphase II oocytes retrieved (11.9 ± 5.5 versus 12.0 ± 5.1), 2-pronuclei fertilization rate (67.2 versus 65.8%), the pregnancy and the implantation rates were not different between the study and control groups (49.0 and 23.6% versus 50.0 and 23.3% respectively). CONCLUSION: Low-dose prednisolone treatment in addition to the standard protocol before and after embryo replacement does not appear to have a significant effect on pregnancy or implantation rates.

Key words: assisted reproduction/glucocorticoids/implantation rate/prednisolone/pregnancy rate

3 To whom correspondence should be addressed at: Centre for Reproductive Medicine, European Hospital, Via Portuense 700–00148, Rome, Italy. E-mail: ubaldi.fm{at}tin.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
H.M. Fatemi, B. Popovic-Todorovic, E. Papanikolaou, P. Donoso, and P. Devroey
An update of luteal phase support in stimulated IVF cycles
Hum. Reprod. Update, November 1, 2007; 13(6): 581 - 590.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Dias, R. McNamee, and A. Vail
Evidence of improving quality of reporting of randomized controlled trials in subfertility
Hum. Reprod., October 1, 2006; 21(10): 2617 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. Strowitzki, A. Germeyer, R. Popovici, and M. von Wolff
The human endometrium as a fertility-determining factor
Hum. Reprod. Update, September 1, 2006; 12(5): 617 - 630.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. D. Keay, P. Vandekerckhove, and J. M. Jenkins
Any effect of adjuvant low dose prednisolone on follicular development and embryo implantation may be masked by the concomitant use of aspirin
Hum. Reprod., January 1, 2003; 18(1): 218 - 219.
[Full Text] [PDF]


Home page
Hum ReprodHome page
F. Ubaldi
Any effect of adjuvant low dose prednisolone on follicular development and embryo implantation may be masked by the concomitant use of aspirin
Hum. Reprod., January 1, 2003; 18(1): 219 - 219.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.